Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Alembic Pharma clears USFDA inspection at oncology unit in Panelav

      Alembic Pharma clears USFDA inspection at oncology unit in Panelav

      Farhat Nasim29 Jun 2019 10:02 AM IST
      This was a first scheduled inspection and Alembic Pharma passed the inspection without any Form 483 Observation.New Delhi: Alembic Pharmaceuticals...
      Regeneron Pharma gets USFDA nod for Dupixent to treat rhinosinusitis with nasal polyps

      Regeneron Pharma gets USFDA nod for Dupixent to treat rhinosinusitis with nasal polyps

      Farhat Nasim29 Jun 2019 10:00 AM IST
      The efficacy and safety of Dupixent were established in two studies with 724 patients, 18 years and older with chronic rhinosinusitis with nasal...
      Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft

      Drug marketers as liable as Drug Manufacturers for quality, efficacy, regulatory compliance: Health Ministry Issues Draft

      Farhat Nasim28 Jun 2019 4:44 PM IST
      New Delhi: Through a recent draft Gazette notification, the Ministry of Health and Family Welfare has informed that not just drugmakers but drug...
      Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

      Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

      Farhat Nasim28 Jun 2019 11:10 AM IST
      The approval by the US Food and Drug Administration (USFDA) is for a generic version of Mirabegron ER tablets of strengths 25 mg and 50 mg, Lupin said...
      FSSAI plans compulsory display of RED colour-coding for packed food with high fat, sugar, salt content

      FSSAI plans compulsory display of RED colour-coding for packed food with high fat, sugar, salt content

      Farhat Nasim27 Jun 2019 6:05 PM IST
      FSSAI noted that food labelling serves as a primary link of communication between the manufacturer and consumer and covers both food safety and...
      Sun Pharma to develope, commercialise Cyclosporine eye drops in Greater China

      Sun Pharma to develope, commercialise Cyclosporine eye drops in Greater China

      Farhat Nasim27 Jun 2019 4:38 PM IST
      Sun Pharma acquired global rights and intellectual property for Cyclosporine A 0.09% ophthalmic solution through the acquisition of Ocular...
      NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details

      NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details

      Farhat Nasim27 Jun 2019 4:07 PM IST
      New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
      Sterling Biotech Bank Fraud: ED seize assets including business jet, ships, oil rings worth over Rs 9700 crore

      Sterling Biotech Bank Fraud: ED seize assets including business jet, ships, oil rings worth over Rs 9700 crore

      Farhat Nasim27 Jun 2019 9:45 AM IST
      New Delhi: Gujarat-based Sterling Biotech is in for more trouble as probe agency, Enforcement Directorate(ED) has recently issued a provisional order...
      Dr Reddys launches generic version of Tobi in US market

      Dr Reddys launches generic version of Tobi in US market

      Farhat Nasim26 Jun 2019 3:07 PM IST
      The product is a therapeutic equivalent generic version of TOBI (tobramycin) Inhalation Solution, approved by the U.S. Food and Drug Administration...
      Alembic Pharma gets USFDA nod for generic version of Tamiflu capsules

      Alembic Pharma gets USFDA nod for generic version of Tamiflu capsules

      Farhat Nasim25 Jun 2019 11:54 AM IST
      The approved product, Oseltamivir Phosphate capsule is therapeutically equivalent to the reference listed drug (RLD), Tamiflu Capsules of Hoffman-La...
      Indian Immunologicals invests Rs 75 crore to set up new Sterile Filling Facility in Telangana

      Indian Immunologicals invests Rs 75 crore to set up new Sterile Filling Facility in Telangana

      Farhat Nasim25 Jun 2019 11:36 AM IST
      With this investment of Rs 75 crores in the upcoming filling facility, Indian Immunologicals Limited expects to increase its capacity to supply...
      Neuland Labs gets 5 USFDA observations for Bonthapally facility

      Neuland Labs gets 5 USFDA observations for Bonthapally facility

      Farhat Nasim24 Jun 2019 6:25 PM IST
      Hyderabad: City-based Neuland Labs recently said that the US health regulator has issued a total of 5 observations after inspection of its Unit 1...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok